Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clozapine effectiveness in treatment-resistant schizophrenia and schizoaffective disorder
2021-001278-44Phase 2Active
- Sponsor
- Fundación Hospital Provincial de Castellón
- Start
- Sep 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of clozapine in schizophrenia and schizoaffective disorder (2 arms), sponsored by Fundación Hospital Provincial de Castellón. Primary endpoint: Change in PANSS score. Started Sep 2021; status: active.
02
Drugs
clozapine
03
Conditions
schizophreniaschizoaffective disorder
Beyond the preview
Go deeper on 2021-001278-44.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-001278-44.